Medscape

Novel Surveillance Tool Raises Flags on Vascular Closure Device

BURLINGTON, MA — An active surveillance system now available as an open-source tool found that the relative risk of vascular complications was increased 60% for patients receiving Mynx (Cardinal ...
WGN-TV

Cordis receives FDA approval for MYNX CONTROL™ VENOUS Vascular Closure Device

Approval brings proven technology of the MYNX family of products to mid-bore venous puncture sites, including electrophysiology procedures. MIAMI, July 9, 2024 /PRNewswire/ -- Cordis, a global leader ...
Becker's Hospital Review

Researchers link higher surgical complication rates to FDA-approved vascular-closure device

Patients who underwent surgery to repair punctured arteries had a significantly higher risk of complications when surgeons used a vascular-closure device manufactured by Cardinal Health, compared to ...
TCTMD

TCT 999: ReliaSeal Trial: A Randomized Trial of Multiple Venous Access Closure With MYNX CONTROL™ VENOUS Vascular Closure Device and Manual Compression After Catheter-Based ...

Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting ...
Mena FN

Vascular Closure Devices Market Set For Steady Growth At 5.70% CAGR Through 2032: Delveinsight Abbott, Teleflex, And Medtronic

"Vascular Closure Devices Market Report"Key global players include Abbott, Teleflex Incorporated, Terumo Medical Corporation, Cardinal Health, Haemonetics Corporation, Merit Medical Systems, Medtronic ...